Visionary Wealth Advisors

Position in VKTX — Viking Therapeutics, Inc.

CIK 1802984 O'FALLON, IL

Position in VKTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$741,228

+$15,606 QoQ

Shares Held

22,779

+10.4% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

6 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Visionary Wealth Advisors holds $1,693,202 across 5 Biotechnology names. VKTX ranks #1 (43.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc. This page	22,779	$741,228
2	IBRX	ImmunityBio, Inc.	58,760	$450,689
3	HALO	Halozyme Therapeutics, Inc.	5,195	$335,752
4	MESO	Mesoblast Ltd	10,325	$158,798
5	CUE	Cue Biopharma, Inc.	29,285	$6,735

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$741,228	22,779	+10.4%	Shares	Sole	2026-05-13
2025-12-31	$725,622	20,626	-4.7%	Shares	Sole	2026-02-13
2025-09-30	$568,962	21,650	+167.4%	Shares	Sole	2025-11-13
2025-06-30	$214,570	8,097	-38.5%	Shares	Sole	2025-08-14
2025-03-31	$318,152	13,174	+262.0%	Shares	Sole	2025-05-14
2024-09-30	$230,385	3,639	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.